Researchers Identify Glioblastoma Vulnerability for Enhanced Treatment

Ohio State University Wexner Medical Center researchers found a new weakness in glioblastoma, a deadly brain cancer. By blocking the SET protein, they prevented tumor formation in preclinical models and increased cancer cell susceptibility to radiation. This discovery offers a new strategy to improve existing treatments for this aggressive cancer.